Acesso a medicamentos pela população brasileira: dados da pesquisa nacional de saúde 2019
Introduction: access to medication is a global challenge, especially in developing countries, which is why data from population surveys are essential to measure related factors. In addition, the high prevalence of people with chronic diseases and, consequently, who make continuous use of medication,...
Na minha lista:
| Autor principal: | |
|---|---|
| Outros Autores: | |
| Formato: | doctoralThesis |
| Idioma: | pt_BR |
| Publicado em: |
Universidade Federal do Rio Grande do Norte
|
| Assuntos: | |
| Endereço do item: | https://repositorio.ufrn.br/handle/123456789/52259 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
| Resumo: | Introduction: access to medication is a global challenge, especially in developing countries, which is why data from population surveys are essential to measure related factors. In addition, the high prevalence of people with chronic diseases and, consequently, who make continuous use of medication, implies the need to guarantee this access through efficient public policies. Objective: to analyze access to medicines in Brazil and associated factors, based on data from the 2019 National Health Survey (PNS). Methods: this is a crosssectional population-based study that used data from the 2019 PNS, enabling the writing from three studies: 1 – general assessment of access to medication by the Brazilian population, based on Andersen's behavioral model; 2 – analysis of factors associated with access to medication for the treatment of arterial hypertension and diabetes; 3 – study of factors associated with the use of medication for the treatment of depression. In the three studies, descriptive analysis was performed, followed by multivariate analysis, considering the independent variables that presented a significance level greater than 95%. Results: in article
1, it was found that the greatest chances of not having access to medication at the individual level were among individuals aged between 40 and 59 years, women, people with complete primary education and complete secondary education, with lower family income, among the who attended public services, individuals with worse self-rated health and those who sought health services for disease prevention and health promotion. In article 2, data regarding access via the Popular Pharmacy Program of Brazil (PFPB) and public service were analyzed. There was greater access to medication for hypertension and oral medication for diabetes via PFPB
and the factors that most influenced this access were higher age group, lower income, lower education, not having health insurance and reporting a very poor self-rated health. Access to insulin, in turn, was more prevalent via the public health service, and the factors that most influenced this access were black/brown race, lower income, not having a health plan and reporting a very poor self-rated health. In article 3, it was found that the factors associated with the use of medication prescribed for depression in the last two weeks were marital status, self-rated health, prevalence of sleep problems, routine medical appointments, and time since
diagnosis of depression. illness. Conclusions: access to medication in the Brazilian population is related to socioeconomic and health perception factors. In general, the importance of the PFPB as a policy to expand access to essential medicines in Brazil is proven, considering the free use of antihypertensive and antidiabetic drugs, as well as the weaknesses of the public health system in Brazil in the supply of medicines. Furthermore,
these findings can guide the updating or formulation of public policies on medicines and pharmaceutical assistance, promoting better mechanisms for the purchase of medicines by the user and, consequently, reducing health inequities. |
|---|